Cargando…

Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation

BACKGROUND: EAST‐AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) demonstrated clinical benefit of early rhythm‐control therapy (ERC) in patients with new‐onset atrial fibrillation (AF) and concomitant cardiovascular conditions compared with current guideline‐based practi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dickow, Jannis, Kirchhof, Paulus, Van Houten, Holly K., Sangaralingham, Lindsey R., Dinshaw, Leon H. W., Friedman, Paul A., Packer, Douglas L., Noseworthy, Peter A., Yao, Xiaoxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238730/ https://www.ncbi.nlm.nih.gov/pubmed/35621202 http://dx.doi.org/10.1161/JAHA.121.024214

Ejemplares similares

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial( )
por: Eckardt, Lars, et al.
Publicado: (2022)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021)

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial
por: Gottschalk, Sophie, et al.
Publicado: (2023)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
por: Schnabel, Renate B, et al.
Publicado: (2022)

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018)

Recent advances in rhythm control for atrial fibrillation
por: Bond, Richard, et al.
Publicado: (2017)

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
por: Kirchhof, Paulus
Publicado: (2017)

Artificial intelligence—electrocardiography to detect atrial fibrillation: trend of probability before and after the first episode
por: Christopoulos, Georgios, et al.
Publicado: (2022)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology
por: Akar, Joseph G, et al.
Publicado: (2020)

Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives
por: Rottner, Laura, et al.
Publicado: (2020)

Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Treatment Strategy, Characteristics of Consecutive Atrial Tachycardia and Long‐Term Outcome
por: Dinshaw, Leon, et al.
Publicado: (2021)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Is Atrial Fibrillation Management as Simple as ABC?
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Catheter ablation in patients with persistent atrial fibrillation
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC – AFNET 9
por: Fabritz, Larissa, et al.
Publicado: (2022)

Rationale and current perspective for early rhythm control therapy in atrial fibrillation
por: Van Gelder, Isabelle C., et al.
Publicado: (2011)

The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification
por: Wynn, Gareth J., et al.
Publicado: (2014)

Almanac 2015: atrial fibrillation research in Heart
por: Jawad-Ul-Qamar, Muhammad, et al.
Publicado: (2016)

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2022)

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
por: Haeusler, Karl Georg, et al.
Publicado: (2015)

An Introduction to Murine Models of Atrial Fibrillation
por: Riley, Genna, et al.
Publicado: (2012)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
por: Rillig, Andreas, et al.
Publicado: (2021)

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
por: Willems, Stephan, et al.
Publicado: (2019)

Self-palpation for detection of paroxysmal atrial fibrillation: Much noise with little signal
por: Rahimi, Kazem, et al.
Publicado: (2020)

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study
por: Reinecke, Holger, et al.
Publicado: (2022)

AFNet Algorithm for Automatic Amniotic Fluid Segmentation from Fetal MRI
por: Costanzo, Alejo, et al.
Publicado: (2023)

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Generalizable and robust deep learning algorithm for atrial fibrillation diagnosis across geography, ages and sexes
por: Biton, Shany, et al.
Publicado: (2023)

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)
por: Kirchhof, Paulus, et al.
Publicado: (2014)

Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?
por: Kany, Shinwan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4d81o6c3hvb35fiiiis75natbf